Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Antiviral Res. 2015 Sep 25;123:114–119. doi: 10.1016/j.antiviral.2015.09.008

Table 1.

Composition of DAS181-F03 and DAS181-F04 Dry Powder

Component wt/wt (%) DAS181-F03 DAS181-F04 Function
DAS181 70.08 65.06 Active Pharmaceutical Ingredient
Histidine 10.11 10.09 Prevent oligomerization
Trehalose 9.23 8.50 Moisture binding
MgSO4 0.00 6.16 Counter ion
Citric Acid 2.53 2.13 Counter ion
Sodium Acetate 0.04 0.03 Maintaining pH
Acetic Acid 0.03 0.01 Maintaining pH
Water 8.00 8.00 N/A
Total 100.00 100.00